Natera: Use of Lucrative CPT Code Could Draw Scrutiny from Georgia Regulators

Published on Feb 09, 2021

Over the course of two years, genetic testing company Natera (NTRA) billed Georgia’s state Medicaid program more than 6,700 times for one expensive and complex test for rare genetic disorders, receiving over $4.2 million dollars from the state and its managed care organizations. A Capitol Forum analysis of claims data received via FOIA request, however, […]

Already have an account? Log in.

This article is currently locked and only available to subscribers. Request a trial to receive unlimited access to all articles.

View Only Unlocked Articles

© 2024 the Capitol Forum